Skip to main content
Header image

Journals

ROSS, A., C. LEAHY, F. NEYLON, J. STEIGEROVÁ, P. FLODR, M. NAVRATILOVA, H. URBANKOVA, K. VRZALIKOVA, L. MUNDO, S. LAZZI, L. LEONCINI, M. PUGH, P. MURRAY
Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma. Life - Basel. 2023, 13(2), 521, ISSN: 2075-1729, PMID: 36836878,  PDF.
VAŇKOVÁ, B., V. KRCHŇÁK, M. SOURAL, J. HLAVÁČ
Direct C-H Arylation of Purine on Solid Phase and Its Use for Chemical Libraries Synthesis. ACS Combinatorial Science. 2011, 13(5), 496-500, ISSN: 2156-8952, PMID: 21675766,
BERTA, E., J. SROVNAL, P. DYTRYCH, J. BRUTHANS, J. ULRICHOVÁ, P. PRASIL, L. VECERA, T. GABRHELIK, B. TOLMACI, J. DUSA, J. MACA, M. MAZACOVA, F. HAJDUK, M. KUTEJ, P. IHNAT, P. MICHALEK, M. HAJDÚCH
Influence of opioid analgesia type on circulating tumor cells in open colorectal cancer surgery (POACC-1): study protocol for a prospective randomized multicenter controlled trial. BMC Anesthesiology. 2023, 23(1), 64, ISSN: 1471-2253, PMID: 36855089,
BALIK, V., H. SLAVÍK, J. SROVNAL
In Reply: Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence. Neurosurgery. 2023, 19(3), e74-e75, ISSN: 0148-396X, PMID: 36700746,
KOVALOVA, M., J. BARAKA, V. MIK, R. JORDA, M. LUO, H. SHAO, V. KRYŠTOF
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022). Expert Opinion on Therapeutic Patents. 2023, 33(2), 67-87, ISSN: 1354-3776, PMID: 36975020,  PDF.
NAVARRO, C., A. ORTEGA, R. SANTELIZ, B. GARRIDO, M. CHACIN, N. GALBAN, I. VERA, J. DE SANCTIS, V. BERMUDEZ
Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches. Pharmaceutics. 2022, 14(6), 1303, ISSN: 1999-4923, PMID: 35745875,  PDF.
ZACHOVÁ, K., J. JEMELKOVA, P. KOSZTYU, Y. OHYAMA, K. TAKAHASHI, J. ZADRAZIL, J. ORSAG, K. MATOUSOVIC, D. GALUSZKOVÁ, N. PETEJOVA, J. MESTECKY, M. RAŠKA
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors. Journal of the American Society of Nephrology. 2022, 33(5), 908-917, ISSN: 1046-6673, PMID: 35115327,
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 2023, 41(2), 210-219, ISSN: 0167-6997, PMID: 36913160,  PDF.
BIELNIKOVA-KRYŠTOFOVA, H., O. MOTYKA, V. ŽIDLÍK, D. ZIAK, I. SZOTKOVSKA, J. ŠKARDA, J. VOVES, J. POMETLOVA, L. PLEVA, M. HAVLICEK, K. CABANOVA
Immunohistochemical evaluation of tissues following bone implant extraction from upper and lower limb. Histology and Histopathology. 2023, ISSN: 0213-3911, PMID: 36928509,
SAID, M., W. ELDEHNA, A. NOCENTINI, S. FAHIM, A. BONARDI, A. ELGAZAR, V. KRYŠTOF, D. SOLIMAN, H. ABDEL-AZIZ, P. GRATTERI, S. ABOU-SERI, C. SUPURAN
Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. European Journal of Medicinal Chemistry. 2020, 189(2020), 112019, ISSN: 0223-5234, PMID: 31972394,